carcinoembryonic antigen-expressing measles virus
Vaccineexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2004 (NCT00408590)
Timeline
2000s
- Jan 1, 2004
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Carcinoembryonic antigen-related cell adhesion molecule 5Immunity, active
CEACAM5 immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- carcinoembryonic antigen-expressing measles virus
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00390299 | Phase 1 | Oct 1, 2006 | Mayo Clinic, National Cancer Institute (NCI) |
| NCT00408590 | Phase 1 | Apr 1, 2004 | Mayo Clinic, National Cancer Institute (NCI) |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Mayo Clinic | Academic/Hospital | 2 | 2 | 1 | 2004 |
| National Cancer Institute (NCI) | Government | 2 | 0 | 1 | 2004 |
2 organizations
Page 1 / 1